Phase I, first-in-human study of futibatinib, a highly selective, irreversible FGFR1–4 inhibitor in patients with advanced solid tumors
Bahleda, R., Meric-Bernstam, F., Goyal, L., Tran, B., He, Y., Yamamiya, I., Benhadji, K.A., Matos, I., Arkenau, H.-T.
Published in Annals of oncology (01.10.2020)
Published in Annals of oncology (01.10.2020)
Get full text
Journal Article
Systematic evaluation of pembrolizumab dosing in patients with advanced non-small-cell lung cancer
Chatterjee, M., Turner, D.C., Felip, E., Lena, H., Cappuzzo, F., Horn, L., Garon, E.B., Hui, R., Arkenau, H.-T., Gubens, M.A., Hellmann, M.D., Dong, D., Li, C., Mayawala, K., Freshwater, T., Ahamadi, M., Stone, J., Lubiniecki, G.M., Zhang, J., Im, E., De Alwis, D.P., Kondic, A.G., Fløtten, Ø.
Published in Annals of oncology (01.07.2016)
Published in Annals of oncology (01.07.2016)
Get full text
Journal Article
Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience
Olmos, D., Arkenau, H.-T., Ang, J.E., Ledaki, I., Attard, G., Carden, C.P., Reid, A.H.M., A'Hern, R., Fong, P.C., Oomen, N.B., Molife, R., Dearnaley, D., Parker, C., Terstappen, L.W.M.M., de Bono, J.S.
Published in Annals of oncology (01.01.2009)
Published in Annals of oncology (01.01.2009)
Get full text
Journal Article
A phase I dose escalation study of AT9283, a small molecule inhibitor of aurora kinases, in patients with advanced solid malignancies
Arkenau, H.-T., Plummer, R., Molife, L.R., Olmos, D., Yap, T.A., Squires, M., Lewis, S., Lock, V., Yule, M., Lyons, J., Calvert, H., Judson, I.
Published in Annals of oncology (01.05.2012)
Published in Annals of oncology (01.05.2012)
Get full text
Journal Article
Second primary colorectal cancers (SPCRCs): experiences from a large Australian Cancer Registry
Ringland, C. L., Arkenau, H.-T., O'Connell, D. L., Ward, R. L.
Published in Annals of oncology (01.01.2010)
Published in Annals of oncology (01.01.2010)
Get full text
Journal Article
The role of intrathecal chemotherapy prophylaxis in patients with diffuse large B-cell lymphoma
Arkenau, H-T, Chong, G, Cunningham, D, Watkins, D, Agarwal, R, Sirohi, B, Trumper, M, Norman, A, Wotherspoon, A, Horwich, A
Published in Annals of oncology (01.03.2007)
Published in Annals of oncology (01.03.2007)
Get full text
Journal Article
An extended phase Ib study of epertinib, an orally active reversible dual EGFR/HER2 tyrosine kinase inhibitor, in patients with solid tumours
Arkenau, H.-T., Italiano, A., Mak, G., Toulmonde, M., Baird, R.D., Garcia-Corbacho, J., Plummer, R., Flynn, M., Forster, M., Wilson, R.H., Tosi, D., Adenis, A., Donaldson, K., Posner, J., Kawabata, I., Arimura, A., Deva, S., Spicer, J.
Published in European journal of cancer (1990) (01.11.2018)
Published in European journal of cancer (1990) (01.11.2018)
Get full text
Journal Article
Efficacy of TAS-120, an irreversible fibroblast growth factor receptor inhibitor (FGFRi), in patients with cholangiocarcinoma and FGFR pathway alterations previously treated with chemotherapy and other FGFRi’s
Tran, B., Meric-Bernstam, F., Arkenau, H.-T., Bahleda, R., Kelley, R.K., Hierro, C., Ahn, D., Zhu, A., Javle, M., Winkler, R., He, H., Huang, J., Goyal, L.
Published in Annals of oncology (01.11.2018)
Published in Annals of oncology (01.11.2018)
Get full text
Journal Article
Clinical benefit in Phase-I trials of novel molecularly targeted agents: does dose matter?
POSTEL-VINAY, S, ARKENAU, H.-T, OLMOS, D, ANG, J, BARRIUSO, J, ASHLEY, S, BANERJI, U, DE-BONO, J, JUDSON, I, KAYE, S
Published in British journal of cancer (05.05.2009)
Published in British journal of cancer (05.05.2009)
Get full text
Journal Article
Towards an optimal treatment algorithm for metastatic pancreatic ductal adenocarcinoma (PDA)
Uccello, M, Moschetta, M, Mak, G, Alam, T, Henriquez, C Murias, Arkenau, H-T
Published in Current oncology (Toronto) (01.02.2018)
Published in Current oncology (Toronto) (01.02.2018)
Get full text
Journal Article
Overall survival results from a phase III trial of trifluridine/tipiracil (FTD/TPI) vs placebo in patients (Pts) with metastatic gastric cancer refractory to standard therapies (TAGS)
Shitara, K., Tabernero, J., Dvorkin, M., Mansoor, W., Arkenau, H.-T., Prokharau, A., Alsina, M., Ghidini, M., Faustino, C., Gorbunova, V., Zhavrid, E., Nishikawa, K., Hosokawa, A., Ganea, D., Yalçın, Ş., Fujitani, K., Beretta, G., Winkler, R., Doi, T., Ilson, D.H.
Published in Annals of oncology (01.11.2018)
Published in Annals of oncology (01.11.2018)
Get full text
Journal Article
Impact of body composition on survival of PD-1/PD-L1-treated metastatic gastro-esophageal junction/gastric cancer
Morelli, C., Formica, V., Roselli, M., Arkenau, HT
Published in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (01.11.2022)
Published in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (01.11.2022)
Get full text
Journal Article
Circulating tumour DNA experience in patients with cancer of unknown primary
Winter, H., Faull, I., Bains, P., Murias, C., Kushnir, M., Forster, M.D., Kulkarni, A., Moore, D., Swanton, C., Shiu, K., Arkenau, H.-T.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Phase I/II study of ODM-203, a selective dual FGFR/VEGFR inhibitor, in patients with advanced solid tumours
Bono, P, Massard, C, Peltola, K, Azaro, A, Italiano, A, Kristeleit, R S, Lassen, U N, Arkenau, H-T, Hakulinen, P, Garratt, C, Ikonen, T, Mustonen, M, Rodon, J
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
A phase I trial of vorolanib (X-82t vascular endothelial growth factor receptor (VEGFR) inhibitor, in patients (pts) with advanced solid tumors
Bendell, J., Moore, K.N., Patel, M.R., Chua, C., Arkenau, H.-T., Dukart, G., Harrow, K., Liang, C.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Match-adjusted indirect comparison of durvalumab and chemotherapy for locally advanced or metastatic urothelial carcinoma (UC) following failure of platinum-based therapy
Hoyle, C.K., Klein, A.B., Patel, K.A., Shire, N., Wang, H., Chu, B.C., Ouwens, M., Nordstrom, B.L., Horne, L., Arkenau, H.-T.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Trifluridine/tipiracil versus placebo for third or later lines of treatment in metastatic gastric cancer: an exploratory subgroup analysis from the TAGS study
Tabernero, J., Shitara, K., Zaanan, A., Doi, T., Lorenzen, S., Van Cutsem, E., Fornaro, L., Catenacci, D.V.T., Fougeray, R., Moreno, S.R., Azcue, P., Arkenau, H.-T., Alsina, M., Ilson, D.H.
Published in ESMO open (01.08.2021)
Published in ESMO open (01.08.2021)
Get full text
Journal Article